Clinical Trials Logo

Depression clinical trials

View clinical trials related to Depression.

Filter by:

NCT ID: NCT06430333 Not yet recruiting - Depression Clinical Trials

Sleep to Reduce Incident Depression Effectively in Peripartum

STRIDE P
Start date: October 1, 2025
Phase: N/A
Study type: Interventional

Perinatal depression (PND) is the most common complication in pregnancy and postpartum, which increases risk for adverse perinatal outcomes such as preterm birth, maternal suicidal thoughts, and impaired mother-infant bonding. Insomnia often precedes PND cases and may serve as an entry point for interventions preventing PND. The proposed project is a large-scale clinical trial to test the effectiveness of a mindfulness-based sleep program designed for pregnant women to improve sleep and alleviate cognitive arousal to reduce risk for PND across pregnancy and postpartum.

NCT ID: NCT06429956 Not yet recruiting - Depression Clinical Trials

Combining Treatment Components in Transdiagnostic Therapy for Anxiety and Depression

Start date: June 2024
Phase: N/A
Study type: Interventional

The present study is a randomized controlled trial that will evaluate the effect of combining two treatment components (i.e., cognitive restructuring and detached mindfulness) drawn from cognitive behavioral therapies (CBTs) that are often combined in clinical practice. However, knowledge about the effect of combining these treatment components is lacking. Therefore, this study aims to explore single, combined, and sequencing effects of these two treatment components in patients with depression and/or anxiety disorders. Furthermore, the study aims to explore possible demographic and clinical moderators of the effects to address the question of what works for whom.

NCT ID: NCT06429722 Recruiting - Clinical trials for Major Depressive Episode Associated With Bipolar II Disorder

To Evaluate the Effects of NMRA-335140 on Symptoms of Major Depression in Participants With Bipolar II Disorder.

Start date: May 13, 2024
Phase: Phase 2
Study type: Interventional

This is a randomized, double-blind, placebo-controlled pilot study aiming to evaluate the effects of NMRA-335140 on symptoms of major depression in adults with Bipolar (BP) II disorder. The study design consists of a Screening Period (up to 28 days), a 6-week Treatment Period (during which participants will receive either NMRA-335140 or placebo), and a 6-week Safety Follow-up Period.

NCT ID: NCT06429514 Completed - Depression Clinical Trials

Study on the Mechanism of Ganoderma Lucidum Spore Powder in the Treatment of Depression

Start date: March 28, 2023
Phase: N/A
Study type: Interventional

To clarify the clinical effect of Ganoderma lucidum spore powder intervention on postoperative depressive symptoms of papillary thyroid carcinoma ; to elucidate the antidepressant mechanism of Ganoderma lucidum spore powder.

NCT ID: NCT06428786 Not yet recruiting - Depression Clinical Trials

The Effect of Polycystic Ovary Syndrome Phenotypes on Quality of Life and Sexual Function

PCOS
Start date: May 25, 2024
Phase:
Study type: Observational [Patient Registry]

This study was planned to examine whether different phenotypes of PCOS have an effect on quality of life, depression inventory and sexual function.

NCT ID: NCT06427902 Completed - Depression Clinical Trials

Inflammatory Biomarkers in Saliva at Depression

Start date: December 10, 2018
Phase:
Study type: Observational

The goal of this observational study is to evaluate the inflammatory saliva biomarkers in depression and gingivitis. The main question will be ; Will there be an increase at salivary biomarkers with depression patients and is it associated with gingivitis?

NCT ID: NCT06426342 Not yet recruiting - Clinical trials for Depression and Suicide

Development and Feasibility of a Metaverse-based Blended Online Intervention to Prevent Employees' Depression

Start date: July 30, 2024
Phase: N/A
Study type: Interventional

The goal of this feasibility study is to develop a new metaverse-based blended online intervention using an online program and coaching via metaverse to prevent depression among Generation MZ Employees in South Korea. In addition, this study primarily explores reach and acceptability and secondarily evaluates the preliminary effectiveness of this preventive intervention on Korea's Gen MZ Employees.

NCT ID: NCT06424496 Completed - Clinical trials for Postpartum Depression

Effect of Targeted Health Education Program on Nurses' Awareness About Postpartum Depression

PPD
Start date: February 28, 2024
Phase: N/A
Study type: Interventional

To assess nurses' knowledge of PPD at Ain Shams University Maternity Hospital and measure their knowledge level after an educational program on postpartum depression.

NCT ID: NCT06424184 Not yet recruiting - Depression Clinical Trials

Accelerated rTMS for Substance Use Disorder and Depression

Start date: June 2024
Phase: N/A
Study type: Interventional

This study is a small open-label feasibility trial of an accelerated course of repetitive transcranial magnetic stimulation (rTMS) for individuals with depression and stimulant use disorder [including methamphetamine or cocaine use disorder (MUD/CUD)].

NCT ID: NCT06423781 Not yet recruiting - Clinical trials for Major Depressive Disorder

Long-term Safety Study of BHV-7000 in Participants With Major Depressive Disorder (MDD)

Start date: July 2024
Phase: Phase 2
Study type: Interventional

The purpose of this study is to evaluate the long-term safety and tolerability of BHV-7000, in participants with Major Depressive Disorder (MDD).